4//SEC Filing
Ganot Ilan 4
Accession 0001193125-26-004953
CIK 0001707502other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 6:52 PM ET
Size
10.6 KB
Accession
0001193125-26-004953
Insider Transaction Report
Form 4
Ganot Ilan
Director
Transactions
- Exercise/Conversion
Common Stock
2026-01-03+2,994→ 18,331 total(indirect: By Spouse) - Sale
Common Stock
2026-01-05$5.43/sh−1,053$5,718→ 17,278 total(indirect: By Spouse) - Exercise/Conversion
Restricted Stock Units
2026-01-03−2,994→ 2,994 total(indirect: By Spouse)→ Common Stock (2,994 underlying)
Holdings
- 95,413
Common Stock
- 19,394(indirect: See Footnote)
Common Stock
Footnotes (5)
- [F1]Restricted stock units convert to common stock on a one-for-one basis.
- [F2]This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The sales do not represent a discretionary trade by Ms. Ganot.
- [F3]Represents 91,371 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.
- [F4]Represents 19,394 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.
- [F5]On January 3, 2023 (the "Grant Date"), Ms. Ganot was granted 11,975 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.
Documents
Issuer
Solid Biosciences Inc.
CIK 0001707502
Entity typeother
Related Parties
1- filerCIK 0001727460
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 6:52 PM ET
- Size
- 10.6 KB